Bone marrow produces sufficient alloreactive natural killer (NK) cells in vivo to cure mice from subcutaneously and intravascularly injected 4T1 breast cancer

Michel van Gelder*, Ariane Vanclee, Catharina H. M. J. van Elssen, Pierre Hupperets, Lotte Wieten, Gerard M. Bos

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)421-433
Number of pages13
JournalBreast Cancer Research and Treatment
Volume161
Issue number3
DOIs
Publication statusPublished - Feb 2017

Keywords

  • 4T1
  • Breast cancer
  • Immunotherapy
  • Alloreactive NK cell
  • Hematopoietic stem cell transplantation
  • KIR-LIGAND INCOMPATIBILITY
  • VERSUS-LEUKEMIA ACTIVITY
  • ACUTE MYELOID-LEUKEMIA
  • MHC CLASS-I
  • T-CELLS
  • TUMOR-CELLS
  • ADOPTIVE IMMUNOTHERAPY
  • ACTIVATING RECEPTORS
  • HEMATOPOIETIC SCT
  • SUPPRESSOR-CELLS

Cite this